Inactivated Poliomyelitis Vaccine (IPV) 2022-2024 (2024-2025, 2025-2026)

The Ministry of Social Affairs and Health (hereinafter ”STM”) and Finnish institute for health and welfare (hereinafter "THL" or “Customer” ) request your tender for Inactivated Poliomyelitis (IPV) Vaccine belonging to the National Vaccination Programme in Finland. The contract period is about two years 2022-2024. The procurement contains two options to extend the contract for the periods 2024-2025 and 2025-2026. The contract will be awarded to one Supplier based on a comparison of tenders. Tender that is economically the most advantageous will win the competition.

The purpose of STM and the Customer is to procure Inactivated Poliomyelitis Vaccine (IPV) required for the National Vaccination Programme in Finland. The tendered vaccine must be suitable for children, adolescents and adults. More information about National Vaccination Programme and vaccinations can be found on the website of the Finnish Institute for Health and Welfare: https://thl.fi/en/web/infectious-diseases-and-vaccinations/vaccines-a-to-z/polio-vaccine The Customer will implement the procurement on behalf of STM. The roles of STM and Customer are described in more detail in section "Presentation of the contracting authority".

The procurement is detailed in the contract notice published on TED (Tenders Electronic Daily) online version and on the Hilma electronic procurement portal at www.hankintailmoitukset.fi as well as in this Call for Tender and its Annexes.